Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
T47D AZD7762
3.1623
CHK1/2
Cell cycle
0.2905 0.06193
T47D Volasertib
0.0031623
PLK
Cell cycle
1.0642 -0.00098
T47D Volasertib
1.0
PLK
Cell cycle
-0.1585 0.16311
T47D Volasertib
0.001
PLK
Cell cycle
1.0155 -0.00006
T47D Volasertib
0.31623
PLK
Cell cycle
-0.0906 0.16641
T47D Volasertib
0.01
PLK
Cell cycle
0.8485 0.00521
T47D Volasertib
0.1
PLK
Cell cycle
-0.0044 0.13769
T47D Dinaciclib
0.0031623
pan CDK
Cell cycle
1.1013 -0.00122
T47D Cisplatin
0.0010833
Chemo
Chemotherapy
1.0538 -0.00313
T47D Trametinib
0.0001
MEK
MAPK/nRTK
0.9279 0.00423
T47D Dinaciclib
1.0
pan CDK
Cell cycle
-0.2109 0.12913
T47D Dinaciclib
0.031623
pan CDK
Cell cycle
-0.0592 0.05833
T47D Topotecan
0.0010833
Topo I
Chemotherapy
0.8845 -0.00136
T47D Cisplatin
0.1
Chemo
Chemotherapy
0.9180 -0.00007
T47D Cisplatin
0.0033333
Chemo
Chemotherapy
1.0424 0.00001
T47D Doxorubicin
0.00031623
Chemo
Chemotherapy
0.8837 0.00193
T47D Cisplatin
10.0
Chemo
Chemotherapy
0.1019 0.03321
T47D Cisplatin
0.31623
Chemo
Chemotherapy
0.8420 -0.00135
T47D Cisplatin
3.1623
Chemo
Chemotherapy
0.2284 0.01447
T47D Doxorubicin
3.1623
Chemo
Chemotherapy
-0.1901 0.17524
T47D Doxorubicin
0.01
Chemo
Chemotherapy
-0.0015 0.03141
T47D Taxol
1.0
Chemo
Chemotherapy
-0.1337 0.41010
T47D Doxorubicin
0.0031623
Chemo
Chemotherapy
0.2335 0.02430
T47D Doxorubicin
1.0
Chemo
Chemotherapy
-0.3611 0.36359
T47D Doxorubicin
0.031623
Chemo
Chemotherapy
-0.0535 0.04115